Oncopeptides AB (publ) (LON: 0RN4)

Oncopeptides AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21	57	91	52	1,028	568
Market Cap Growth	-44.72%	-37.99%	76.62%	-94.98%	80.91%	11.11%
Enterprise Value	11	47	58	-3	917	478
Last Close Price	0.10	0.43	0.69	0.48	10.79	7.29
PS Ratio	17.05	20.57	137.15	5.35	-	-
PB Ratio	3.40	12.76	3.89	3.00	19.99	8.82
P/TBV Ratio	3.40	12.76	3.89	3.02	20.05	8.85
EV/Sales Ratio	5.43	17.01	86.70	-	-	-
Debt / Equity Ratio	0.86	1.97	0.02	0.07	0.03	0.02
Asset Turnover	0.09	0.11	0.02	0.17	-	-
Quick Ratio	6.16	4.26	4.22	1.78	2.44	5.65
Current Ratio	6.25	4.52	4.25	1.83	2.52	5.88
Return on Equity (ROE)	-209.92%	-141.91%	-133.80%	-363.13%	-232.14%	-139.49%
Return on Assets (ROA)	-57.08%	-50.66%	-52.59%	-134.59%	-97.95%	-67.38%
Return on Capital (ROIC)	-70.95%	-67.42%	-82.55%	-227.14%	-134.96%	-86.79%
Earnings Yield	-100.94%	-34.38%	-29.49%	-226.15%	-13.83%	-10.53%
FCF Yield	-87.42%	-38.59%	-36.92%	-239.82%	-11.39%	-9.83%
Buyback Yield / Dilution	-50.76%	-9.80%	-9.33%	-20.72%	-20.63%	-20.43%
Total Shareholder Return	-50.76%	-9.80%	-9.33%	-20.72%	-20.63%	-20.43%

Source: S&P Capital IQ. Standard template. Financial Sources.